Literature DB >> 24084491

Culturing and maintaining Clostridium difficile in an anaerobic environment.

Adrianne N Edwards1, Jose M Suárez, Shonna M McBride.   

Abstract

Clostridium difficile is a Gram-positive, anaerobic, sporogenic bacterium that is primarily responsible for antibiotic associated diarrhea (AAD) and is a significant nosocomial pathogen. C. difficile is notoriously difficult to isolate and cultivate and is extremely sensitive to even low levels of oxygen in the environment. Here, methods for isolating C. difficile from fecal samples and subsequently culturing C. difficile for preparation of glycerol stocks for long-term storage are presented. Techniques for preparing and enumerating spore stocks in the laboratory for a variety of downstream applications including microscopy and animal studies are also described. These techniques necessitate an anaerobic chamber, which maintains a consistent anaerobic environment to ensure proper conditions for optimal C. difficile growth. We provide protocols for transferring materials in and out of the chamber without causing significant oxygen contamination along with suggestions for regular maintenance required to sustain the appropriate anaerobic environment for efficient and consistent C. difficile cultivation.

Entities:  

Mesh:

Year:  2013        PMID: 24084491      PMCID: PMC3871928          DOI: 10.3791/50787

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  34 in total

1.  Comparison of three anaerobic systems for the isolation of anaerobic bacteria from clinical specimens.

Authors:  G E Killgore; S E Starr; V E Del Bene; D N Whaley; V R Dowell
Journal:  Am J Clin Pathol       Date:  1973-04       Impact factor: 2.493

2.  Clindamycin-associated colitis. A prospective study.

Authors:  F J Tedesco; R W Barton; D H Alpers
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

3.  Cultivation of anaerobic intestinal bacteria.

Authors:  B S Drasar
Journal:  J Pathol Bacteriol       Date:  1967-10

4.  The release of oxygen from polystyrene Petri dishes.

Authors:  C J Koch; J Kruuv
Journal:  Br J Radiol       Date:  1972-10       Impact factor: 3.039

5.  Transferable tetracycline resistance in Clostridium difficile.

Authors:  C J Smith; S M Markowitz; F L Macrina
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

6.  SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins.

Authors:  Emily E Putnam; Adam M Nock; Trevor D Lawley; Aimee Shen
Journal:  J Bacteriol       Date:  2013-01-04       Impact factor: 3.490

7.  Prospective study of gram-stained stool smears in diagnosis of Clostridium difficile colitis.

Authors:  C J Shanholtzer; L R Peterson; M N Olson; D N Gerding
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

8.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

9.  Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.

Authors:  K H Wilson; M J Kennedy; F R Fekety
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

10.  Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis.

Authors:  K H Wilson; J Silva; F R Fekety
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

View more
  46 in total

1.  Regulation and Anaerobic Function of the Clostridioides difficile β-Lactamase.

Authors:  Brindar K Sandhu; Adrianne N Edwards; Sarah E Anderson; Emily C Woods; Shonna M McBride
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  A novel regulator controls Clostridium difficile sporulation, motility and toxin production.

Authors:  Adrianne N Edwards; Rita Tamayo; Shonna M McBride
Journal:  Mol Microbiol       Date:  2016-03-22       Impact factor: 3.501

3.  Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile.

Authors:  Adrianne N Edwards; Kathryn L Nawrocki; Shonna M McBride
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

4.  Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability.

Authors:  Carlos Augusto Oliveira Júnior; Rodrigo Otávio Silveira Silva; Diogo Soares Gonçalves Cruz; Isadora Honorato Pires; Guilherme Guerra Alves; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2018-12-18       Impact factor: 2.476

5.  CodY-Dependent Regulation of Sporulation in Clostridium difficile.

Authors:  Kathryn L Nawrocki; Adrianne N Edwards; Nadine Daou; Laurent Bouillaut; Shonna M McBride
Journal:  J Bacteriol       Date:  2016-07-13       Impact factor: 3.490

6.  Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.

Authors:  Jenessa A Winston; Rajani Thanissery; Stephanie A Montgomery; Casey M Theriot
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

7.  Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240.

Authors:  Emily C Woods; Daniela Wetzel; Monjori Mukerjee; Shonna M McBride
Journal:  Anaerobe       Date:  2018-06-22       Impact factor: 3.331

8.  A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice.

Authors:  Chrstine Bäuerl; Özgun C O Umu; Pablo E Hernandez; Dzung B Diep; Gaspar Pérez-Martínez
Journal:  J Vis Exp       Date:  2017-07-25       Impact factor: 1.355

9.  The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor σV in Response to Lysozyme.

Authors:  Emily C Woods; Kathryn L Nawrocki; Jose M Suárez; Shonna M McBride
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

10.  Isolating and Purifying Clostridium difficile Spores.

Authors:  Adrianne N Edwards; Shonna M McBride
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.